Form 4: Alignment Healthcare CFO Sells Shares Under 10b5-1 Plan

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 39,320 shares of common stock at an average price of $12.0384 under a pre-arranged 10b5-1 trading plan.

Summary

• On October 8, 2024, Robert Thomas Freeman, the Chief Financial Officer of Alignment Healthcare, Inc. (ALHC), sold 39,320 shares of the company's common stock.
• The sale was executed under a pre-arranged trading plan pursuant to Rule 10b5-1(c), which was adopted on March 15, 2024.
• The shares were sold at a weighted-average price of $12.0384, with individual sales prices ranging from $12.00 to $12.20 per share.
• Following the transaction, Mr. Freeman directly owns 865,407 shares of Alignment Healthcare common stock.
• Mr. Freeman also indirectly owns 194,609 shares through FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine stock sale under a pre-arranged plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading as the plan was established before the transaction.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially leading to short-term price fluctuations, although the 10b5-1 plan mitigates this risk.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are generally viewed as less indicative of management sentiment than discretionary sales.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares, but the 10b5-1 plan helps to mitigate concerns about insider information.

Key Dates